Does Alcohol Consumption during Multidrug-resistant Tuberculosis Treatment Affect Outcome?
Supporting Files
-
6 2014 ; 6-2014
-
Available in CDC Stacks on 2015-11-03T00:00:00Z
File Language:
English
Details
-
Alternative Title:Ann Am Thorac Soc
-
Personal Author:
-
Description:Rationale ; India reports the largest number of multidrug-resistant tuberculosis cases in the world; yet, no longitudinal study has assessed factors related to treatment outcomes under programmatic conditions in the public sector. ; Objectives ; To describe demographic, clinical, and risk characteristics associated with treatment outcomes for all patients with multidrug-resistant tuberculosis registered in the Revised National Tuberculosis Control Programme, Kerala State, India from January 1, 2009 to June 30, 2010. ; Methods ; Cox regression methods were used to calculate adjusted hazard ratios with 95% confidence intervals (CIs) to assess factors associated with an unsuccessful treatment outcome. ; Measurements and Main Results ; Of 179 patients with multidrug-resistant tuberculosis registered, 112 (63%) had successful treatment outcomes (77 bacteriologically cured, 35 treatment completed) and 67 (37%) had unsuccessful treatment outcomes (30 died, 26 defaulted, 9 failed treatment, 1 stopped treatment because of drug-related adverse events, and 1 developed extensively drug-resistant tuberculosis). The hazard for unsuccessful outcome was significantly higher among patients who consumed alcohol during treatment (adjusted hazard ratio, 4.3; 95% CI, 1.1–17.6) than those who did not. Persons who consumed alcohol during treatment, on average, missed 18 more intensive-phase doses (95% CI, 13–22) than those who did not. Although many patients had diabetes (33%), were ever smokers (39%), or had low body mass index (47%), these factors were not associated with outcome. ; Conclusion ; Overall treatment success was greater than global and national averages; however, outcomes among patients consuming alcohol remained poor. Integration of care for multidrug-resistant tuberculosis and alcoholism should be considered to improve treatment adherence and outcomes.
-
Keywords:
- multidrug-resistant tuberculosis treatment outcome
- multidrug-resistant tuberculosis
- alcohol
- tuberculosis
- India
- Adult
- Alcohol Drinking
- Antitubercular Agents
- Female
- Follow-Up Studies
- Humans
- Incidence
- India
- Male
- Middle Aged
- Mycobacterium tuberculosis
- Population Surveillance
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Sputum
- Survival Rate
- Treatment Outcome
- Tuberculosis, Multidrug-Resistant
-
Source:Ann Am Thorac Soc. 11(5):712-718
-
Pubmed ID:24735096
-
Pubmed Central ID:PMC4631605
-
Document Type:
-
Funding:
-
Volume:11
-
Issue:5
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha256:325d3884f865c46ca5fd31ab83fa446a65f1bb4a20190f0afa3af90c1a8beb37
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access